Auxilium Pharmaceuticals (AUXL) PT, Estimates Raised at Jefferies on Headcount Reduction
Jefferies analyst Thomas Wei raised estimates and his price target on Buy-rated Auxilium Pharmaceuticals (NASDAQ: AUXL) to $34.00 (from $32.00) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)